JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnston, M. G.
Right arrow Articles by Feuer, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnston, M. G.
Right arrow Articles by Feuer, C.

Suppression of lymphatic vessel contractility with inhibitors of arachidonic acid metabolism

MG Johnston and C Feuer

Contractions of lymphatic vessels play an important role in regulating lymph flow; however, little is known of the pharmacological properties of these vessels and the mechanisms regulating the contractions. Earlier work had suggested that arachidonic acid metabolites may play some role in the contractile process and in this report we have assessed the effects of various inhibitors of arachidonate metabolism on the contractions of bovine mesenteric lymphatic rings suspended in tissue baths. Aspirin and indomethacin (cyclooxygenase inhibitors), BW 755C (a cyclooxygenase and lipoxygenase inhibitor) and FPL 55712 (a slow reacting substance of anaphylaxis-leukotriene-antagonist) suppressed the phasic contractions of spontaneously active vessels. The addition of arachidonate to noncontracting vessels elicited phasic and tonic contractile activities which were similarly blocked with these drugs, as were the contractions elicited with several agonists. These results suggest that lymphatic vessel contractions are extremely susceptible to suppression with inhibitors of arachidonate metabolism implying that these drugs may alter extravascular fluid dynamics by a direct effect on the lymphatic vessel. The intrinsic contractile regulatory mechanism may involve the production of arachidonate products within the vessel.

Volume 226, Issue 2, pp. 603-607, 08/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. F. Wu, C. J. Carati, W. K. MacNaughton, and P.-Y. von der Weid
Contractile activity of lymphatic vessels is altered in the TNBS model of guinea pig ileitis
Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G566 - G574.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. K Chan, N. Vergnolle, M. D Hollenberg, and P.-Y. von der Weid
Proteinase-activated receptor 2 activation modulates guinea-pig mesenteric lymphatic vessel pacemaker potential and contractile activity
J. Physiol., October 15, 2004; 560(2): 563 - 576.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics.